[ Price : $8.95]
CDER Office of Compliance director Jill Furman highlights a year of sweeping operational shifts, heightened enforcement, and emerg...[ Price : $8.95]
FDA commissioner Marty Makary alleges that the Biden administration failed to disclose internal data on myocarditis risks in young...[ Price : $8.95]
Former FDA associate commissioner Peter Pitts says CDER director Richard Pazdurs decision to abruptly retire was motivated by grow...[ Price : $8.95]
Capricor Therapeutics says Deramiocel, a cell therapy candidate targeting cardiomyopathy associated with Duchenne muscular dystrop...[ Price : $8.95]
The CDER Accelerating Rare Disease Cures program Year-Three report shows a decline in new drug approvals and several other activit...[ Price : $8.95]
The American Hospital Association suggests ways for FDA to develop a regulatory framework for measuring and evaluating AI-enabled ...[ Price : $8.95]
A new Bloomberg report finds that two Republican lawmakers were barred from attending a 12/3 FDA meeting concerning the potential ...[ Price : $8.95]
FDA awards Eli Lilly traditional approval for Jaypirca (pirtobrutinib) and its use in adults with relapsed or refractory chronic l...